Fellowship training at City of Hope will focus on the treatment of patients with diabetes, including patients with type 1, type 2 and those with drug and disease-induced forms of diabetes, such as that seen in cancer patients on steroid therapy and IV nutritional support. The fellows will gain experience with advanced monitoring and treatment strategies for diabetes, including continuous glucose monitoring, oral medications, and insulin pump therapy. At City of Hope, the fellows will also participate in the ongoing clinical islet transplantation program and will be involved in the screening and follow-up care of islet transplant recipients with and without prior renal transplants. Fellows will also gain important experience with the diagnosis and management of diabetes-related complications and diabetes-associated disorders, including acute metabolic deteriorations, retinopathy, neuropathy, hyperlipidemia, hypertension, coronary disease, peripheral vascular disease and sexual dysfunction. Fellows will also receive training on the implementation of non-drug strategies for the management of diabetes and its complications, including weight reduction and behavioral modification. Furthermore, at City of Hope, the fellows will receive training in other endocrine disciplines, including: thyroid disorders and thyroid cancers, adrenal gland dysfunctions and tumors, pituitary gland disorders, metabolic abnormalities associated with cancer and its treatments, and osteoporosis and other metabolic bone diseases.

The training at Harbor-UCLA will be useful to the City of Hope endocrine fellows as it will provide them with an introduction in the care of underserved populations. It will also allow the fellows to gain experience with management of disease manifestations and disorders that are not frequently encountered in the populations seeking care at City of Hope (i.e., severe neuropathy requiring leg amputation and vision-threatening retinopathy) as well as gestational diabetes. Another benefit from the association with Harbor-UCLA is to maintain a high level of academic challenge for City of Hope faculty through continuing interactions with the faculty and trainees of another highly rated program. Physicians participating in the joint fellowship program at City of Hope and Harbor-UCLA will have the opportunity to receive training in islet transplantation that will prepare them to meet the requirements set by the United Network of Organ Sharing (UNOS), a national organ procurement agency, for establishing new islet transplantation centers.

Curriculum
City of Hope endocrinology fellows will be primarily allocated to the City of Hope site where they will receive the majority of their training. A segment of their education will also be completed at the Harbor-UCLA program site. Similarly, endocrine fellows at Harbor-UCLA will have the opportunity to receive a portion of their training at City of Hope. This type of curriculum will expose fellows to a wider range of endocrine disciplines including: type 1 and type 2 diabetes, gestational diabetes, diabetes-related complications, diabetes-associated disorders, clinical islet transplantation, thyroid disorders and thyroid cancer, adrenal gland dysfunctions and tumors, pituitary gland disorders, metabolic abnormalities associated with cancer, osteoporosis, and sexual dysfunction. Upon completion of the program, endocrine fellows are expected to be fully trained in the treatment and management of endocrinology-related diseases and disorders.

Training Requirements
Physicians with a MD degree, at any stage of their postdoctoral training, will be considered for the program. Preference will be given to those who have completed residency in Internal Medicine, Pediatrics, Ob/Gyn, Urology or other related specialties. The program is also well suited for postdoctoral training for candidates with PhD degrees. All candidates who have completed at least 3 years of residency in the United States must possess a California license to practice and do clinical training.

Hospital Facilities
The City of Hope National Medical Center was established in 1913 as a charitable hospital supported by a philanthropic volunteer organization. It has 917,137 square feet of clinical, laboratory, and administrative space, dedicated to the prevention and cure of life-threatening diseases, such as cancer and diabetes, through both innovative research and compassionate patient care. The Diabetes Program at City of Hope was established in 1971 by Rachmiel Levine, M.D., and is currently led by Fouad Kandeel, M.D., Ph.D. in The Leslie and Susan Gonda (Goldschmied) Diabetes and Genetic Research Center, a 43,000 square foot, state-of-the-art research building.

Please Send Inquiries About City of Hope To:
Fouad Kandeel, MD, PhD
Director, Department of Diabetes, Endocrinology and Metabolism
City of Hope National Medical Center
1500 East Duarte Road
Duarte, CA 91010
Phone: (626) 256-HOPE (4673) ext. 62689
Fax: (626) 301-8489
Email: fkandeel@coh.org